longtext: 4C4Y-pdb

content
HEADER    HYDROLASE                               09-SEP-13   4C4Y
TITLE     CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE HYDROXYLASE
TITLE    2 2 COMPLEXED WITH A4
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: BIFUNCTIONAL EPOXIDE HYDROLASE 2;
COMPND   3 CHAIN: A;
COMPND   4 FRAGMENT: EPOXIDE HYDROXYLASE DOMAIN, RESIDUES 230-255;
COMPND   5 SYNONYM: CYTOSOLIC EPOXIDE HYDROLASE 2, CEH, EPOXIDE HYDRATASE,
COMPND   6  SOLUBLE EPOXIDE HYDROLASE, SEH, LIPID-PHOSPHATE PHOSPHATASE,
COMPND   7  BIFUNCTIONAL EPOXIDE HYDROXYLASE 2;
COMPND   8 EC: 3.3.2.10, 3.1.3.76;
COMPND   9 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE   3 ORGANISM_COMMON: HUMAN;
SOURCE   4 ORGANISM_TAXID: 9606;
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE   9 EXPRESSION_SYSTEM_VECTOR: PET16B
KEYWDS    HYDROLASE, DRUG DESIGN
EXPDTA    X-RAY DIFFRACTION
AUTHOR    J.PILGER,A.MAZUR,P.MONECKE,H.SCHREUDER,B.ELSHORST,T.LANGER,
AUTHOR   2 A.SCHIFFER,I.KRIMM,M.WEGSTROTH,D.LEE,G.HESSLER,K.-U.WENDT,S.BECKER,
AUTHOR   3 C.GRIESINGER
REVDAT   1   01-OCT-14 4C4Y    0
JRNL        AUTH   J.PILGER,A.MAZUR,P.MONECKE,H.SCHREUDER,B.ELSHORST,T.LANGER,
JRNL        AUTH 2 A.SCHIFFER,I.KRIMM,M.WEGSTROTH,D.LEE,G.HESSLER,K.-U.WENDT,
JRNL        AUTH 3 S.BECKER,C.GRIESINGER
JRNL        TITL   A COMBINATION OF SPIN DIFFUSION METHODS FOR THE
JRNL        TITL 2 DETERMINATION OF PROTEIN-LIGAND COMPLEX STRUCTURAL
JRNL        TITL 3 ENSEMBLES
JRNL        REF    TO BE PUBLISHED
JRNL        REFN
REMARK   2
REMARK   2 RESOLUTION.    2.41 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : BUSTER 2.11.2
REMARK   3   AUTHORS     : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK   3               : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK   3               : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 40.82
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.0
REMARK   3   COMPLETENESS FOR RANGE        (%) : 96.82
REMARK   3   NUMBER OF REFLECTIONS             : 11906
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD           : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM
REMARK   3   R VALUE     (WORKING + TEST SET)  : 0.2608
REMARK   3   R VALUE            (WORKING SET)  : 0.2581
REMARK   3   FREE R VALUE                      : 0.3148
REMARK   3   FREE R VALUE TEST SET SIZE   (%)  : 4.86
REMARK   3   FREE R VALUE TEST SET COUNT       : 579
REMARK   3   ESTIMATED ERROR OF FREE R VALUE   : NULL
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED               : 6
REMARK   3   BIN RESOLUTION RANGE HIGH   (ANGSTROMS) : 2.41
REMARK   3   BIN RESOLUTION RANGE LOW    (ANGSTROMS) : 2.64
REMARK   3   BIN COMPLETENESS (WORKING+TEST)     (%) : 96.82
REMARK   3   REFLECTIONS IN BIN (WORKING + TEST SET) : 2598
REMARK   3   BIN R VALUE        (WORKING + TEST SET) : 0.3827
REMARK   3   REFLECTIONS IN BIN        (WORKING SET) : 2461
REMARK   3   BIN R VALUE               (WORKING SET) : 0.3797
REMARK   3   BIN FREE R VALUE                        : 0.4338
REMARK   3   BIN FREE R VALUE TEST SET SIZE      (%) : 5.27
REMARK   3   BIN FREE R VALUE TEST SET COUNT         : 137
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE     : NULL
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 2535
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 15
REMARK   3   SOLVENT ATOMS            : 139
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 42.14
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 37.02
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 1.1279
REMARK   3    B22 (A**2) : -11.2022
REMARK   3    B33 (A**2) : 10.0743
REMARK   3    B12 (A**2) : 0.0000
REMARK   3    B13 (A**2) : 0.0000
REMARK   3    B23 (A**2) : 0.0000
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT                    (A) : 0.477
REMARK   3   DPI (BLOW EQ-10) BASED ON R VALUE        (A) : 1.798
REMARK   3   DPI (BLOW EQ-9) BASED ON FREE R VALUE    (A) : 0.370
REMARK   3   DPI (CRUICKSHANK) BASED ON R VALUE       (A) : 0.957
REMARK   3   DPI (CRUICKSHANK) BASED ON FREE R VALUE  (A) : 0.363
REMARK   3
REMARK   3   REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK   3               CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK   3
REMARK   3 CORRELATION COEFFICIENTS.
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.8444
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.7755
REMARK   3
REMARK   3   NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK   3   TERM                          COUNT    WEIGHT   FUNCTION.
REMARK   3    BOND LENGTHS              : 2626   ; 2.00   ; HARMONIC
REMARK   3    BOND ANGLES               : 3558   ; 2.00   ; HARMONIC
REMARK   3    TORSION ANGLES            : 900    ; 2.00   ; SINUSOIDAL
REMARK   3    TRIGONAL CARBON PLANES    : 61     ; 2.00   ; HARMONIC
REMARK   3    GENERAL PLANES            : 376    ; 5.00   ; HARMONIC
REMARK   3    ISOTROPIC THERMAL FACTORS : 2626   ; 20.00  ; HARMONIC
REMARK   3    BAD NON-BONDED CONTACTS   : NULL   ; NULL   ; NULL
REMARK   3    IMPROPER TORSIONS         : NULL   ; NULL   ; NULL
REMARK   3    PSEUDOROTATION ANGLES     : NULL   ; NULL   ; NULL
REMARK   3    CHIRAL IMPROPER TORSION   : 315    ; 5.00   ; SEMIHARMONIC
REMARK   3    SUM OF OCCUPANCIES        : NULL   ; NULL   ; NULL
REMARK   3    UTILITY DISTANCES         : NULL   ; NULL   ; NULL
REMARK   3    UTILITY ANGLES            : NULL   ; NULL   ; NULL
REMARK   3    UTILITY TORSION           : NULL   ; NULL   ; NULL
REMARK   3    IDEAL-DIST CONTACT TERM   : 2999   ; 4.00   ; SEMIHARMONIC
REMARK   3
REMARK   3   RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3    BOND LENGTHS                       (A) : 0.007
REMARK   3    BOND ANGLES                  (DEGREES) : 0.93
REMARK   3    PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.78
REMARK   3    OTHER TORSION ANGLES         (DEGREES) : 19.35
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 4C4Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-SEP-13.
REMARK 100 THE PDBE ID CODE IS EBI-58282.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 30-NOV-11
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 8.3
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SLS
REMARK 200  BEAMLINE                       : X06DA
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0000
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : NULL
REMARK 200
REMARK 200  DETECTOR TYPE                  : PIXEL (PILATUS 6M)
REMARK 200  DETECTOR MANUFACTURER          : DECTRIS
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200  DATA SCALING SOFTWARE          : SCALA
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 12191
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.41
REMARK 200  RESOLUTION RANGE LOW       (A) : 57.24
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : -3.0
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.9
REMARK 200  DATA REDUNDANCY                : 5.6
REMARK 200  R MERGE                    (I) : 0.08
REMARK 200  R SYM                      (I) : NULL
REMARK 200   FOR THE DATA SET  : 15.00
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.41
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.54
REMARK 200  COMPLETENESS FOR SHELL     (%) : 97.8
REMARK 200  DATA REDUNDANCY IN SHELL       : 5.7
REMARK 200  R MERGE FOR SHELL          (I) : 0.33
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200   FOR SHELL         : 4.60
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 3OTQ
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 41.7
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP. 1 UL PROTEIN
REMARK 280  SOLUTION (8 MG/ML SEH IN 100 MM NAPO2, PH 7.4, 5 MM DTT
REMARK 280  AND 15% GLYCEROL) WAS MIXED WITH 1 UL RESERVOIR SOLUTION
REMARK 280  (100 MM TRIS-HCL, PH 8.3, 26% PEG4000 AND 200 MM LI2SO4
REMARK 280  AND EQUILIBRATED AT 20C. CRYSTALS APPEARED IN ABOUT 2
REMARK 280  WEEKS
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y,-Z
REMARK 290       3555   X+1/2,-Y,-Z+1/2
REMARK 290       4555   -X+1/2,-Y,Z+1/2
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       40.82000
REMARK 290   SMTRY2   3  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       40.14500
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       40.82000
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       40.14500
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375      HOH A2004   LIES ON A SPECIAL POSITION.
REMARK 375      HOH A2009   LIES ON A SPECIAL POSITION.
REMARK 375      HOH A2013   LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     THR A   230
REMARK 465     SER A   231
REMARK 465     CYS A   232
REMARK 465     ASN A   233
REMARK 465     ASN A   548
REMARK 465     PRO A   549
REMARK 465     PRO A   550
REMARK 465     VAL A   551
REMARK 465     VAL A   552
REMARK 465     SER A   553
REMARK 465     LYS A   554
REMARK 465     MET A   555
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    GLU A 269     -162.59   -104.45
REMARK 500    ASP A 335     -116.70     59.20
REMARK 500    ASN A 359      -38.80     67.45
REMARK 500    LEU A 480       99.50    -21.63
REMARK 500    LEU A 499       77.73   -107.99
REMARK 500    ILE A 511     -118.50     46.52
REMARK 500    LEU A 514       99.13      5.74
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CHIRAL CENTERS
REMARK 500
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY
REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR
REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)
REMARK 500
REMARK 500  M RES CSSEQI    IMPROPER   EXPECTED   FOUND DETAILS
REMARK 500    ILE A 511        21.9      L          L   OUTSIDE RANGE
REMARK 500    LEU A 514        24.5      L          L   OUTSIDE RANGE
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7WI A1548
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4C4X   RELATED DB: PDB
REMARK 900  CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE
REMARK 900  HYDROXYLASE 2 COMPLEXED WITH C9
REMARK 900 RELATED ID: 4C4Z   RELATED DB: PDB
REMARK 900  CRYSTAL STRUCTURE OF HUMAN BIFUNCTIONAL EPOXIDE
REMARK 900  HYDROXYLASE 2 COMPLEXED WITH A8
DBREF  4C4Y A  230   555  UNP    P34913   HYES_HUMAN     230    555
SEQRES   1 A  326  THR SER CYS ASN PRO SER ASP MET SER HIS GLY TYR VAL
SEQRES   2 A  326  THR VAL LYS PRO ARG VAL ARG LEU HIS PHE VAL GLU LEU
SEQRES   3 A  326  GLY SER GLY PRO ALA VAL CYS LEU CYS HIS GLY PHE PRO
SEQRES   4 A  326  GLU SER TRP TYR SER TRP ARG TYR GLN ILE PRO ALA LEU
SEQRES   5 A  326  ALA GLN ALA GLY TYR ARG VAL LEU ALA MET ASP MET LYS
SEQRES   6 A  326  GLY TYR GLY GLU SER SER ALA PRO PRO GLU ILE GLU GLU
SEQRES   7 A  326  TYR CYS MET GLU VAL LEU CYS LYS GLU MET VAL THR PHE
SEQRES   8 A  326  LEU ASP LYS LEU GLY LEU SER GLN ALA VAL PHE ILE GLY
SEQRES   9 A  326  HIS ASP TRP GLY GLY MET LEU VAL TRP TYR MET ALA LEU
SEQRES  10 A  326  PHE TYR PRO GLU ARG VAL ARG ALA VAL ALA SER LEU ASN
SEQRES  11 A  326  THR PRO PHE ILE PRO ALA ASN PRO ASN MET SER PRO LEU
SEQRES  12 A  326  GLU SER ILE LYS ALA ASN PRO VAL PHE ASP TYR GLN LEU
SEQRES  13 A  326  TYR PHE GLN GLU PRO GLY VAL ALA GLU ALA GLU LEU GLU
SEQRES  14 A  326  GLN ASN LEU SER ARG THR PHE LYS SER LEU PHE ARG ALA
SEQRES  15 A  326  SER ASP GLU SER VAL LEU SER MET HIS LYS VAL CYS GLU
SEQRES  16 A  326  ALA GLY GLY LEU PHE VAL ASN SER PRO GLU GLU PRO SER
SEQRES  17 A  326  LEU SER ARG MET VAL THR GLU GLU GLU ILE GLN PHE TYR
SEQRES  18 A  326  VAL GLN GLN PHE LYS LYS SER GLY PHE ARG GLY PRO LEU
SEQRES  19 A  326  ASN TRP TYR ARG ASN MET GLU ARG ASN TRP LYS TRP ALA
SEQRES  20 A  326  CYS LYS SER LEU GLY ARG LYS ILE LEU ILE PRO ALA LEU
SEQRES  21 A  326  MET VAL THR ALA GLU LYS ASP PHE VAL LEU VAL PRO GLN
SEQRES  22 A  326  MET SER GLN HIS MET GLU ASP TRP ILE PRO HIS LEU LYS
SEQRES  23 A  326  ARG GLY HIS ILE GLU ASP CYS GLY HIS TRP THR GLN MET
SEQRES  24 A  326  ASP LYS PRO THR GLU VAL ASN GLN ILE LEU ILE LYS TRP
SEQRES  25 A  326  LEU ASP SER ASP ALA ARG ASN PRO PRO VAL VAL SER LYS
SEQRES  26 A  326  MET
HET    7WI  A1548      15
HETNAM     7WI 1-(3-CHLOROPHENYL)-3-(2-METHOXYETHYL)UREA
FORMUL   2  7WI    C10 H13 CL N2 O2
FORMUL   3  HOH   *139(H2 O)
HELIX    1   1 SER A  270  ARG A  275  5                                   6
HELIX    2   2 TYR A  276  ALA A  284  1                                   9
HELIX    3   3 ILE A  305  TYR A  308  5                                   4
HELIX    4   4 CYS A  309  LEU A  324  1                                  16
HELIX    5   5 ASP A  335  TYR A  348  1                                  14
HELIX    6   6 SER A  370  ASN A  378  1                                   9
HELIX    7   7 PRO A  379  PHE A  381  5                                   3
HELIX    8   8 ASP A  382  PHE A  387  1                                   6
HELIX    9   9 GLY A  391  ASN A  400  1                                  10
HELIX   10  10 ASN A  400  PHE A  409  1                                  10
HELIX   11  11 THR A  443  LYS A  455  1                                  13
HELIX   12  12 PHE A  459  ASN A  464  1                                   6
HELIX   13  13 ASN A  468  CYS A  477  1                                  10
HELIX   14  14 VAL A  500  GLN A  505  5                                   6
HELIX   15  15 HIS A  506  TRP A  510  5                                   5
HELIX   16  16 TRP A  525  LYS A  530  1                                   6
HELIX   17  17 LYS A  530  ALA A  546  1                                  17
SHEET    1  AA 8 SER A 238  LYS A 245  0
SHEET    2  AA 8 VAL A 248  LEU A 255 -1  O  VAL A 248   N  LYS A 245
SHEET    3  AA 8 ARG A 287  ASP A 292 -1  O  VAL A 288   N  LEU A 255
SHEET    4  AA 8 ALA A 260  CYS A 264  1  O  VAL A 261   N  LEU A 289
SHEET    5  AA 8 ALA A 329  HIS A 334  1  O  VAL A 330   N  CYS A 262
SHEET    6  AA 8 VAL A 352  LEU A 358  1  N  ARG A 353   O  ALA A 329
SHEET    7  AA 8 ALA A 488  ALA A 493  1  O  LEU A 489   N  SER A 357
SHEET    8  AA 8 LYS A 515  ILE A 519  1  O  LYS A 515   N  MET A 490
CISPEP   1 PHE A  267    PRO A  268          0        -5.86
CISPEP   2 ILE A  511    PRO A  512          0         2.57
SITE     1 AC1 10 PHE A 267  ASP A 335  TRP A 336  MET A 339
SITE     2 AC1 10 TYR A 383  PHE A 387  LEU A 408  TYR A 466
SITE     3 AC1 10 HIS A 524  TRP A 525
CRYST1   81.640   46.340   80.290  90.00  90.00  90.00 P 21 2 21     4
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.012249  0.000000  0.000000        0.00000
SCALE2      0.000000  0.021580  0.000000        0.00000
SCALE3      0.000000  0.000000  0.012455        0.00000
TER    2536      ARG A 547
MASTER      302    0    1   17    8    0    3    6 2689    1   15   26
END